Treatment of Pain Flashcards
Pharmacologic Approaches
Non-opioid analgesics, opioids, alpha2 adrenergic, antidepressants, anti epileptic, topical/local analgesics, NMDA receptor antagonists, Muscle relaxants
Non opioid analgesics
Mechanism: inhibition of COX
Use: mild to moderate pain, soft tissue injury, strains, sprains, HA, and arthritis
Other: Synergistic when combined with opioid
Side Effects: Acetaminophen is hepatotoxic, NSAIDs and Aspirin cause gastric ulcers and inhibit platelet aggregation
Cautions: Acetaminophen in liver disease and alcoholics, Avoid NSAIDs in patients on aspirin for CV protection
Opioid Receptors
mu, delta, and kappa
all three cause the activation of inwardly rectifying K+ channels, inhibition of Ca2+ channels, and inhibition of adenylyl cyclase
Mu receptor
found in CNS (neocortex, thalamus, nucleus accumbens, hippocampus, and amygdala) and myenteric neurons in gut and vas deferens
mediates supra spinal analgesia, respiratory depression, euphoria, dependence, and mitosis gastric transit
Mu receptor agonists and antagonists
Endogenous agonists: endomorphin 1&2, enkephalins, and beta endorphin
Drug agonists: morphine, fentanyl, methadone, meperidine, buprenorphine
Antagonists: naloxone, naltrexone
Delta Receptor
found in olfactory bulb, nucleus accumbent, caudate, putamen, neocortex
Involved in affective behaviors
Delta Receptor Agonists and antagonists
Endogenous agonists: enkephalins
Drug Agonists: None
Antagonists: Naltrindole
Kappa Receptor
Found in cerebral cortex, nucleus accumbent, claustrum, hypothalamus, spinal cord
Mediates spinal cord analgesia, mitosis, and sedation
Kappa Receptor Agonists and Antagonists
Endogenous agonists: dynorphins
Drug agonists: Butorphanol, Pentazocine, nalbuphine
Strong Opioid Agonists
Morphine, Hydromorphone, Methadone, Heroin, Oxycodone, Meperidine, Fentanyl, Alfentanil, Remifentanil, Sufentanil
Moderate to Low Agonists
Codeine, Propoxyphene
Mixed Agonists/ antagonists
Partial agonists
Buprenorphine, Pentazocine, Butorphanol, Nalbuphine
Antagonists
Naloxone, Naltrexone, Nalmefene
Morphine
Gold Standard, acts at mu receptor impacting respiration, pain perception, mood, and emotion, acts at kappa receptor in spinal cord, prevents substance P release
Use: relief of moderate to severe acute and chronic pain, pulmonary edema, preanesthetic
Interactions: phenothiazines, MAO-Is, TCAs
Contraindication: Hepatic insufficiency, respiratory insufficiency, or head injury
Administered: SC/IM/PO/suppository/pump
Metabolism: glucoronide conjugation with urinary excretion
Morphine effects
analgesia without loss of consciousness, drowsiness, itchy nose, euphoria, dysphoria, nausea and vomiting, miosis, depressed respiration, peripheral vasodilation, constipation, decrease levels of LH and testosterone
Morphine Withdrawal
rebound phenomenon, hyperalgesia, hyperventilation, dilation of pupils, diarrhea, and dysphoria
Cough Suppression
codeine/hydrocodone
decrease sensitivity of CNS cough centers, decrease mucosal secretion
CYP2D6 converts codeine to morphine
Hydromorphone
hydrogenated ketone of morphine, used for severe pain, PO/IV/IM/extended release